Skip to main content
. 2014 Jul 8;186(10):754–760. doi: 10.1503/cmaj.130989

Figure 3:

Figure 3:

Responses to BRAF inhibitors can be dramatic, but relapses are almost invariable and can be equally rapid. Abdominal computed tomographic scans showing peritoneal metastases (dashed white lines) before treatment (A), and after two months (B) and three months (C) of treatment with vemurafenib.